Insights

Clinical-stage Immunotherapy Transgene is a clinical-stage biotechnology company focused on individualized therapeutic vaccines for cancer, signaling potential collaboration opportunities with pharma partners seeking early to mid-stage immunotherapy programs.

Funding Cushion With a funding total of approximately 217 million, Transgene has a strong capital position to support ongoing R&D and potential co-development deals, presenting opportunities for financing partnerships or milestone-driven collaborations.

Revenue Window Current revenue range (1–10 million) alongside substantial funding suggests room for strategic partnerships to accelerate late-stage development, licensing deals, or research collaborations with larger biotechs.

Small-to-Mid Cap Fit Team size and performance indicate suitability for partnerships with mid-sized pharma/biotech players or biotech-focused venture arms seeking incremental value through translational or platform-based vaccine programs.

Individuated Vaccines Specialization in individualized therapeutic vaccines for cancer presents a niche yet growing market segment, ideal for BD outreach around platform licensing, combinatorial therapy collaborations, or access to companion diagnostic capabilities.

Similar companies to Transgene

Amgen
39K$10B+
4D Molecular Therapeutics
215$10M - $25M
Merck
45K$10B+
OSE Immunotherapeutics
83$1M - $10M
Turnstone Biologics
22$10M - $25M

Transgene Tech Stack

Transgene uses 8 technology products and services including Matomo, Cloudflare, WordPress, and more. Explore Transgene's tech stack below.

Matomo
Analytics
Cloudflare
Content Management System
WordPress
Content Management System
CookieYes
Cookie Compliance
Microsoft 365
Email
Vimeo
Video Players
Piwik PRO Core
Web Analytics
WPML
Web Platform Extensions

Transgene's Email Address Formats

Transgene uses at least 4 email formats:

Transgene Email Formats	Example	Percentage
Last@transgene.fr	Doe@transgene.fr	66%
FirstLast@transgene.fr	JohnDoe@transgene.fr	23%
First.Last@transgene.fr	John.Doe@transgene.fr	9%
F.Last@transgene.fr	J.Doe@transgene.fr	2%

Frequently Asked Questions

What is Transgene's phone number?

You can contact Transgene's main corporate office by phone at

+33-3-88-27-9****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Transgene's stock symbol?

Transgene is a publicly traded company; the company's stock symbol is 0OCQ.L.

What is Transgene's official website and social media links?

Transgene's official website is transgene.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Transgene generate?

As of August 2026, Transgene's annual revenue is estimated to be $1M - $10M.

What is Transgene's SIC code and NAICS code?

Transgene's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Transgene have currently?

As of August 2026, Transgene has approximately 206 employees across 3 continents, including Europe, Asia and North America. Key team members include Chief Executive Officer: J. C., Chief Scientific Officer (cso): M. C. and Chief Business Officer: J. W. Explore Transgene's employee directory with LeadIQ.

What industry does Transgene belong to?

Transgene operates in the Biotechnology Research industry.

What technology does Transgene use?

Transgene's tech stack includes Matomo, Cloudflare, WordPress, CookieYes, Microsoft 365, Vimeo, Piwik PRO Core and WPML.

What is Transgene's email format?

Transgene's email format typically follows the pattern of Last@transgene.fr. Find more Transgene email formats with LeadIQ.

How much funding has Transgene raised to date?

As of August 2026, Transgene has raised $217M in funding. The last funding round occurred on Nov 26, 2025 for $16M.

When was Transgene founded?

Transgene was founded in 1979.

Transgene

Q: What is Transgene's official website and social media links?

Transgene's official website is transgene.com. Transgene has social profiles on LinkedIn.

Q: How many employees does Transgene have currently?

Transgene has approximately 206 employees.

Q: What technology does Transgene use?

Transgene's tech stack includes Jetpack, Matomo, LiteSpeed, Cloudflare, OWL Carousel.

Q: What is Transgene's NAICS code?

Transgene's NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Biotechnology ResearchGrand Est, France201-500 Employees

Transgene is a clinical-stage biotechnology company based in Illkirch-Graffenstaden, in the Grand Est region of France, focused on cancer immunotherapy. It develops individualized therapeutic vaccines intended to tailor treatment to the molecular profile of each patient's cancer. Operating in the biotechnology research sector, it seeks to advance personalized vaccine approaches as a modality for cancer treatment. The company is mid-sized and is publicly listed on Euronext under the ticker TNG.

Company Overview

Phone number: +33-3-88-27-9****
Website: transgene.com
SIC Code: 8731 - Commercial Physical and Biological Research
Stock Symbol: 0OCQ.L
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 1979
Employees: 201-500

Funding & Financials

$217M
Transgene has raised a total of $217M of funding over 5 rounds. Their latest funding round was raised on Nov 26, 2025 in the amount of $16M as a Post IPO Equity.
$1M - $10M
Transgene's revenue is estimated to be in the range of $1M - $10M